Jose E. Infante-Arriola

Almeria, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Plasma p-tau217 measured by the Elecsys automated immunoassay: Prospective validation in a heterogeneous memory clinic cohort.

Plasma p-tau217 measured by the Elecsys automated immunoassay: Prospective validation in a heterogeneous memory clinic cohort.

Journal: Journal of Alzheimer's disease : JAD

Published: June 16, 2026

Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease.

Peak width of skeletonized mean diffusivity reveals early and multifactorial white matter injury across sporadic and Down syndrome-associated Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 20, 2026

The predictive power of neuropsychological measures in MCI: early detection of dementia conversion.

The predictive power of neuropsychological measures in MCI: early detection of dementia conversion.

Journal: Frontiers in aging neuroscience

Published: November 05, 2025

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Journal: Lancet (London, England)

Published: October 31, 2025

Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.

Temporal dynamics of white matter hyperintensities related to Alzheimer's disease in adults with Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 22, 2025

Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease.

Alternative TMA-93 version demonstrates comparable performance and discriminative accuracy in early Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: October 16, 2025

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.

Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome.

Journal: Nature communications

Published: July 23, 2025

Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.

Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.

Journal: Neurology

Published: June 05, 2025

TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.

TMA-93 (binding by images): Cutoffs optimization based on Alzheimer's disease biomarkers.

Journal: Journal of Alzheimer's disease : JAD

Published: March 21, 2025

Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic.

Prospective evaluation of plasma pTau217 stability for the detection of Alzheimer's disease in a tertiary memory clinic.

Journal: Alzheimer's research & therapy

Published: March 10, 2025

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.

The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 03, 2025

Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease.

Alpha-synuclein co-pathology in Down syndrome-associated Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: January 31, 2025

Showing 1-12 of 26

Last Updated: 09/26/2026